why choose us

First received: October 18, 2022

Clinical Trial: Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Transplant-Related Disorder

Study Type: INTERVENTIONAL


Official Title: A Prospective, Single-arm Clinical Trial of Prevention of Severe Acute Graft-versus-host Disease After Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation Using a daGOAT Model

Brief Summary: To evaluate the efficacy and safety of ruxolitinib for prophylactic therapy of adult patients who are predicted to have a high risk for developing severe acute graftversus-host disease (aGVHD) by the dynamic aGVHD Onset Anticipation Tianjin (daGOAT) model.

Read more